azathioprine has been researched along with Peripheral Vascular Diseases in 4 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Peripheral Vascular Diseases: Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.
Excerpt | Relevance | Reference |
---|---|---|
"To assess the risk of long-term cardiovascular and metabolic outcomes and all-cause mortality in patients with pemphigus managed by rituximab compared with those receiving treatment with first-line corticosteroid-sparing agents (azathioprine and mycophenolate mofetil [MMF])." | 4.31 | Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus. ( Kridin, K; Ludwig, RJ; Mruwat, N, 2023) |
" Hughes-Stovin syndrome was diagnosed and treatment was started with prednisolone and azathioprine." | 3.71 | [Giant aneurysms of the pulmonary artery and peripheral venous thrombosis (Hughes-Stovin syndrome): regression with immunosuppressant therapy]. ( Alí-Munive, A; Maldonado, D; Torres-Duque, C; Varón, H, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Kridin, K | 3 |
Mruwat, N | 3 |
Ludwig, RJ | 3 |
Taylor, I | 1 |
Doggrell, SA | 1 |
Alí-Munive, A | 1 |
Varón, H | 1 |
Maldonado, D | 1 |
Torres-Duque, C | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Cardiac Allograft Remodeling and Effects of Sirolimus on Its Progression[NCT01889992] | Phase 1 | 42 participants (Actual) | Interventional | 2013-04-24 | Terminated (stopped due to PI left University and project not continued) | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
4 other studies available for azathioprine and Peripheral Vascular Diseases
Article | Year |
---|---|
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.
Topics: Azathioprine; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Immunosuppres | 2023 |
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.
Topics: Azathioprine; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Immunosuppres | 2023 |
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.
Topics: Azathioprine; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Immunosuppres | 2023 |
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.
Topics: Azathioprine; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Immunosuppres | 2023 |
Cavernous hemangioma. Reversible posterior leukoencephalopathy syndrome.
Topics: Adult; Azathioprine; Diabetes Mellitus, Type 1; Diffusion Magnetic Resonance Imaging; Female; Hemang | 2003 |
Is everolimus useful in preventing allograft rejection and vasculopathy after heart transplant?
Topics: Adrenal Cortex Hormones; Aged; Azathioprine; Cholesterol; Cholesterol, LDL; Clinical Trials as Topic | 2004 |
[Giant aneurysms of the pulmonary artery and peripheral venous thrombosis (Hughes-Stovin syndrome): regression with immunosuppressant therapy].
Topics: Adult; Aneurysm; Anti-Inflammatory Agents; Azathioprine; Humans; Immunosuppressive Agents; Male; Per | 2001 |